FDA Public Workshops of Interest: Biomarkers of Neurotoxicity on July 23 & Implementing FDA's Predictive Toxicology Roadmap on September 18
You are invited to attend an FDA public workshop planned for March 29, 2019 titled Leveraging Human-Relevant Cardiomyocytes in Nonclinical Studies to Provide Mechanistic Insights into Cardiovascular Safety Liabilities. Registration required by March 27.
The NC3Rs and the Medicines and Healthcare products Regulatory Agency (MHRA) are working together to host a workshop to overcome barriers to the wider uptake of human tissue based approaches for safety assessment of new drugs.
The workshop is on 15 July 2014 in central London.
Today, 200 registrants participated in our CE Courses, Mini Course and Author Workshop. What a great way to start the Meeting!